𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HIV-1- prevalence among drug deaths in major cities of central and northern Europe

✍ Scribed by K. Püschel; U. Lockemann; V. Schneider; H.-F. Brettel; R. Penning; J. Rajs; A. Fugelstad; B. Kringsholm; D. Risser; B. Vonlanthen


Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
405 KB
Volume
57
Category
Article
ISSN
0379-0738

No coin nor oath required. For personal study only.

✦ Synopsis


Since 1985, a number of Institutes of Forensic Medicine in Germany have cooperated in a multicenter study, to provide a constant monitoring of HIV-1-prevalence among drug related deaths. In 1990/91, the Institutes in Copenhagen, Stockholm, Vienna and Zürich also participated in this study. HIV-1-prevalence is decreasing in the German cities, whereas the epidemiological development is not uniform in the other major cities. Regional differences are obvious. In 1991, the prevalence rates were as follows: Berlin 15% (n = 220), Hamburg 4% (n = 179), Frankfurt 17% (n = 167), Munich 9% (n = 136), Stockholm 10% (n = 79), Copenhagen 14% (n = 130), Vienna 20% (n = 56), and Zürich 23% (n = 84).


📜 SIMILAR VOLUMES


Low prevalence of transmitted drug resis
✍ Dace Balode; Maj Westman; Tatjana Kolupajeva; Baiba Rozentale; Jan Albert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV‐1‐infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in‐house genotypic resistance as

Moderate prevalence of transmitted drug
✍ Adriana Santarém Ferreira; Ludimila Paula Vaz Cardoso; Mariane Martins de Araújo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract Few reports have described the molecular characteristics of the AIDS epidemic within the interior regions of Brazil, a country of continental dimensions. To help fill this gap, the prevalence of transmitted antiretroviral drug resistance and human immunodeficiency virus type 1 (HIV‐1) d